Chemoinformaics analysis of ethyl 3-heptyl ester
| Molecular Weight | 343.511 | nRot | 7 |
| Heavy Atom Molecular Weight | 310.247 | nRig | 11 |
| Exact Molecular Weight | 343.251 | nRing | 2 |
| Solubility: LogS | -6.808 | nHRing | 1 |
| Solubility: LogP | 7.163 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 33 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
| nHA | 3 | APOL | 61.4482 |
| nHD | 0 | BPOL | 37.4198 |
| QED | 0.537 |
| Synth | 2.319 |
| Natural Product Likeliness | -0.301 |
| NR-PPAR-gamma | 0.716 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.989 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.641 |
| MDCK | 0.0000124 |
| BBB | 0.834 |
| PPB | 0.991683 |
| VDSS | 2.687 |
| FU | 0.0209563 |
| CYP1A2-inh | 0.198 |
| CYP1A2-sub | 0.752 |
| CYP2c19-inh | 0.548 |
| CYP2c19-sub | 0.818 |
| CYP2c9-inh | 0.295 |
| CYP2c9-sub | 0.933 |
| CYP2d6-inh | 0.152 |
| CYP2d6-sub | 0.058 |
| CYP3a4-inh | 0.343 |
| CYP3a4-sub | 0.605 |
| CL | 5.642 |
| T12 | 0.334 |
| hERG | 0.008 |
| Ames | 0.17 |
| ROA | 0.565 |
| SkinSen | 0.072 |
| Carcinogencity | 0.634 |
| EI | 0.015 |
| Respiratory | 0.899 |
| NR-Aromatase | 0.466 |
| Antiviral | No |
| Prediction | 0.537676 |